<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04681664</url>
  </required_header>
  <id_info>
    <org_study_id>NSP67</org_study_id>
    <nct_id>NCT04681664</nct_id>
  </id_info>
  <brief_title>Gut Microbiome Based Analysis of High Protein High Fat Diet</brief_title>
  <official_title>Development of Methods and Algorithms to Design Diets Based on Gut Microbiome Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center of Food and Fermentation Technologies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Development, Estonia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Center of Food and Fermentation Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to determine body mass reduction and microbiota composition change&#xD;
      after the weight loss diet (50 % fat, 25 % proteins and 25 % carbohydrates).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For high fat group a total of 19 overweight/obese participants (14 females, 5 males, aged 25&#xD;
      to 43) with BMI of 28.9-44.4 kg/m2 were assigned to low-calorie low-carbohydrate high-fat&#xD;
      weight loss diet for 4 weeks.&#xD;
&#xD;
      As a control group, 58 subjects (39 females, 20 males, aged 24 to 55 years) were recruited&#xD;
      and divided into 3 groups based on BMI: 18-25, 25-30, 30-39 kg/m2 (N=33, N=16, N=9,&#xD;
      respectively).&#xD;
&#xD;
      Inclusion criteria for participants included no previous history of gastrointestinal (GI)&#xD;
      disease, no reported antibiotic use in preceding 3 months, or taking any medication known to&#xD;
      alter bowel motility, no history of food allergies and not taking medications.&#xD;
&#xD;
      Before the study all participants were informed about the study and participants were signed&#xD;
      a written consent.&#xD;
&#xD;
      At day 0 baseline samples and data were collected (faecal sample, Bristol score and bowel&#xD;
      habits, food diary about the period of at least three days before faecal sampling, body&#xD;
      weight). After collection of baseline samples subjects in the high fat group started diet&#xD;
      plan for 4 weeks while control group contiunued their habitual diet. After the 4 week&#xD;
      intervention period samples and data were collected again (faecal sample, Bristol score and&#xD;
      bowel habits, food diary about the period of at least three days before faecal sampling, body&#xD;
      weight).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">November 30, 2017</completion_date>
  <primary_completion_date type="Actual">September 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of body weight during 4 weeks high fat diet</measure>
    <time_frame>Baseline and after 4 weeks</time_frame>
    <description>Body weight was measured by calibrated scale before the study (baseline) and after the diet intervention (4 week)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of inflammation related bacteria in faecal microbiota</measure>
    <time_frame>4 weeks</time_frame>
    <description>Bacterial composition was measured by 16S ribosomal sequencing at baseline and after the 4 weeks diet. The relative change of each bacterial taxon was calculated based on the abundance of the given bacteria at baseline and after 4 weeks high fat diet.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>50 % fat diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the high fat group the subjects were assigned to the diet containing in average 50 % fat, 25 % proteins and 25 % carbohydrates for four weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High fat diet</intervention_name>
    <description>50 % fat</description>
    <arm_group_label>50 % fat diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for obese group:&#xD;
&#xD;
          -  BMI &gt; 30 g/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  antibiotic treatment within last three months;&#xD;
&#xD;
          -  food restrictions due to allergies, any kind of food intolerance,&#xD;
             veganism/vegetarianism or other extremes in food consumption practices;&#xD;
&#xD;
          -  chronic illnesses;&#xD;
&#xD;
          -  current pregnancy or breastfeeding&#xD;
&#xD;
          -  travel to subtropical or tropical regions within one month before the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center of Food and Fermentation Technologies</name>
      <address>
        <city>Tallinn</city>
        <state>Harjumaa</state>
        <zip>12618</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 19, 2020</last_update_submitted>
  <last_update_submitted_qc>December 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microbiome</keyword>
  <keyword>ribosomal sequencing</keyword>
  <keyword>obesity</keyword>
  <keyword>bifidobacteria</keyword>
  <keyword>Collinsella</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol: Study protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 25, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04681664/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 25, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04681664/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 25, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04681664/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

